ECG changes during haloperidol and pimozide treatment of Tourette's disorder

G. Fulop; R. A. Phillips; A. K. Shapiro; J. A. Gomes; J. W. Nordlie

doi:10.1176/ajp.144.5.673

ECG changes during haloperidol and pimozide treatment of Tourette's disorder

G. Fulop, R. A. Phillips, A. K. Shapiro, J. A. Gomes, J. W. Nordlie

Research output: Contribution to journal › Article › peer-review

114 Scopus citations

Abstract

The ECG QTc interval was significantly prolonged by pimozide but not haloperidol or placebo in a randomized clinical trial with 40 patients with Tourette's disorder. However, no adverse cardiac effects or differences in rate, rhythm, or waveform were found.

Original language	English (US)
Pages (from-to)	673-675
Number of pages	3
Journal	American Journal of Psychiatry
Volume	144
Issue number	5
DOIs	https://doi.org/10.1176/ajp.144.5.673
State	Published - 1987

ASJC Scopus subject areas

Psychiatry and Mental health

Access to Document

10.1176/ajp.144.5.673

Cite this

@article{8d936e301455496dbd028088e0805f9a,

title = "ECG changes during haloperidol and pimozide treatment of Tourette's disorder",

abstract = "The ECG QTc interval was significantly prolonged by pimozide but not haloperidol or placebo in a randomized clinical trial with 40 patients with Tourette's disorder. However, no adverse cardiac effects or differences in rate, rhythm, or waveform were found.",

author = "G. Fulop and Phillips, {R. A.} and Shapiro, {A. K.} and Gomes, {J. A.} and Nordlie, {J. W.}",

year = "1987",

doi = "10.1176/ajp.144.5.673",

language = "English (US)",

volume = "144",

pages = "673--675",

journal = "American Journal of Psychiatry",

issn = "0002-953X",

publisher = "American Psychiatric Association",

number = "5",

}

TY - JOUR

T1 - ECG changes during haloperidol and pimozide treatment of Tourette's disorder

AU - Fulop, G.

AU - Phillips, R. A.

AU - Shapiro, A. K.

AU - Gomes, J. A.

AU - Nordlie, J. W.

PY - 1987

Y1 - 1987

N2 - The ECG QTc interval was significantly prolonged by pimozide but not haloperidol or placebo in a randomized clinical trial with 40 patients with Tourette's disorder. However, no adverse cardiac effects or differences in rate, rhythm, or waveform were found.

AB - The ECG QTc interval was significantly prolonged by pimozide but not haloperidol or placebo in a randomized clinical trial with 40 patients with Tourette's disorder. However, no adverse cardiac effects or differences in rate, rhythm, or waveform were found.

UR - http://www.scopus.com/inward/record.url?scp=0023274550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023274550&partnerID=8YFLogxK

U2 - 10.1176/ajp.144.5.673

DO - 10.1176/ajp.144.5.673

M3 - Article

C2 - 3555126

AN - SCOPUS:0023274550

SN - 0002-953X

VL - 144

SP - 673

EP - 675

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

IS - 5

ER -

ECG changes during haloperidol and pimozide treatment of Tourette's disorder

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this